Genaera Corporation Presents Additional Promising Preclinic

**Curis helping to treat cancer, neurological degenerative, kidney disorders, CUDC-101. Pathways, hedgehog, EGFR, Her2, Hsp90, Bcr-Abl/Src, CDK, BCL, MEK, VEGF, HDAC.**

Pathway 2 Curis Forum (Hedgehog and beyond) Forum Index » Clinical Trials News
Reply to topic
Genaera Corporation Presents Additional Promising Preclinic
RSS FEED


Joined: 05 Apr 2006
Posts: 19275
Post Posted: Tue Jun 10, 2008 10:26 am Reply with quote
Genaera Corporation (Nasdaq: GENR) announced a presentation by Genaera scientists of preclinical data on trodusquemine (MSI-1436), Genaera's lead drug candidate for the treatment of type 2 diabetes and obesity, during the 68th Scientific Sessions of the American Diabetes Association in San Francisco, California.

Read more...
View user's profileSend private message
Genaera Corporation Presents Additional Promising Preclinic
All times are GMT - 7 Hours  
Page 1 of 1  
  
  
Pathway 2 Curis Forum (Hedgehog and beyond) Forum Index » Clinical Trials News
 Reply to topic  
Forum Map
Site Map